Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery ...

GenEditBio Limited ("GenEditBio"), a Hong Kong -headquartered clinical-stage biotechnology company specializing in novel deliveries, including lipid nanoparticle (LNP)-based delivery systems, ...

The new GE technology — for which the Indian Council of Agricultural Research (ICAR) has recently been granted a patent — deploys the so-called TnpB or Transposon-associated proteins.

The new knowledge could lead to the use by CBI of renewable microbes and plant cells from poplar trees and switchgrass (two non-edible plants that grow fast) for demonstrating the scaled-up industrial ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

Antibiotics usually save lives—but against some bacteria, they can make things worse. That’s the case with the Shiga toxin–producing Escherichia coli, where bacterial death releases a flood of a ...